Condition
Chronic Subdural Hematoma clinical trials and research
As of November 12, 2026, Find a Trial lists 20 Chronic Subdural Hematoma clinical trials that are recruiting, at sites in 16 countries (most in United States (5), China (3), Finland (2)). By phase: Phase 2/3 (1). There are also 4 NIH-funded research projects on Chronic Subdural Hematoma, with $8.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 20Clinical trials
- 4NIH research projects
- 16Countries
Newest Chronic Subdural Hematoma clinical trials
All recruiting trials (20)
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Coil embolization for unilateral vs bilateral chronic subdural hematomas
This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients
This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.
-
Matched microcatheter and guidewire use for middle meningeal artery embolization in chronic subdural hematoma
This will test whether using a matched Aristotle 14 guidewire and Plato 17 microcatheter during middle meningeal artery embolization works better than surgeons' usual device choices for adults with chronic subdural hematoma.
-
Tranexamic acid plus surgery versus surgery alone for adults with chronic subdural hematoma
This trial will see if adding tranexamic acid to standard burr-hole surgery lowers the chance an adult's chronic subdural hematoma comes back.
-
Continuing versus stopping aspirin during non-surgical management of chronic subdural hematoma
This test tries to see if continuing aspirin or stopping it is safer and leads to better outcomes for adults with chronic subdural hematoma who are being treated without surgery.
-
Comparing endoscope-assisted versus burr-hole drainage for chronic subdural hematoma
This trial will test whether endoscope-assisted drainage works better than standard burr-hole drainage for adults (18–90) with symptomatic, imaging-confirmed chronic subdural hematoma.
-
Effect of positioning after surgery on chronic subdural hematoma recurrence
This study tests if lying in a specific position after surgery can help prevent chronic subdural hematomas from coming back in patients.
-
Embolization of the middle meningeal artery for chronic subdural hematoma
This study is testing if blocking a specific artery can help people with chronic subdural hematomas feel better and recover safely.
-
Registry for understanding chronic subdural hematoma
This study is looking to gather information from adults with chronic subdural hematoma to see how different treatments work and improve care for future patients.
-
Early versus later restart of blood thinners after surgery for chronic subdural hematoma in people with atrial fibrillation
This trial will test whether restarting oral blood thinners 5 days versus 30 days after surgery is safer and better at preventing clots for adults with atrial fibrillation who had surgery for chronic subdural hematoma.
-
Best drainage method after burr hole evacuation for chronic subdural hematoma
This trial tests whether 24 hours of active subperiosteal drainage works as well as 24 hours of passive subdural drainage for adults having a single burr‑hole evacuation of a symptomatic chronic subdural hematoma.
-
Using body posture to prevent recurrence of chronic subdural hematoma after surgery
This study is testing if certain sleeping positions can help prevent chronic subdural hematomas from coming back after surgery.
-
Comparing embolization and surgery for chronic subdural hematoma treatment
This study is testing if a new procedure called middle meningeal artery embolization can be a safer and more effective option than traditional surgery for people with chronic subdural hematomas.
-
Investigating spinal CSF leaks in patients with chronic subdural hematoma
This study looks at whether leaks of spinal fluid might be connected to chronic subdural hematomas in patients to help improve diagnosis and treatment.
-
Evaluating outcomes of middle meningeal artery embolization for chronic subdural hematoma
This study tests if a new, less invasive treatment called middle meningeal artery embolization can safely help adults with chronic subdural hematoma and reduce the chances of it coming back.
-
Minimally invasive treatment for chronic subdural hematoma using cyanoacrylate embolization
This study is testing if adding a new, less invasive treatment using glue to standard surgery can help people with chronic subdural hematoma have better outcomes and lower chances of the condition coming back.
-
Different IV Fluids After Surgery for Chronic Subdural Hematoma
Researchers will test whether giving D5 1/4NS after burr hole drainage helps shrink residual space and lowers recurrence in chronic subdural hematoma patients.
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
NeoCast: A new embolic treatment for chronic subdural hematoma
A new, fast-acting embolic therapy called NeoCast may reduce bleeding in chronic subdural hematoma patients and lower the need for extensive brain surgery.
-
Embolization versus surgery for chronic subdural hematoma
It compares a less-invasive artery-blocking procedure (middle meningeal artery embolization) with standard surgery for adults with moderately symptomatic chronic subdural hematoma.
-
Investigating brain stiffness to predict outcomes in chronic subdural hematoma treatment
This study is looking at how the stiffness of the brain can help doctors understand and treat chronic subdural hematoma (a type of brain bleeding) in older adults, using special imaging to see how the brain responds after treatment.
-
Comparing embolization and surgery for treating chronic subdural hematomas
This study is looking at whether a new treatment called middle meningeal artery embolization (MMAE) is better than traditional surgery for helping people with chronic subdural hematomas, and it’s for patients who have moderate symptoms and want to see if this new option can lead to fewer surgeries and better recovery i
Related topics
Quick answers
How many Chronic Subdural Hematoma clinical trials are recruiting right now?
20, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (5 trials), China (3 trials), Finland (2 trials), Germany (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.